Fig. 2
From: Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination
Anti-HCV prevalence by age and sex. Anti-HCV prevalence was approximately three times higher among men vs. women overall (12.1% vs. 3.8%) and varied by age; among men, prevalence peaked at 22.7% in the 40–49 age group, while it increased steadily with age among women to a maximum of 5.4% among those ≥60 years of age. [Note: *Differences in anti-HCV prevalence between male and female respondents were statistically significant in asterisked categories using Rao-Scott Chi-square tests (p < 0.05)]